Cytokine release syndrome was also a problem with other CAR-T treatments that they work through. Read the long portion on cytokine syndrome with the yescarta

Cytokine release syndrome was also a problem with other CAR-T treatments that they work through. Read the long portion on cytokine syndrome with the yescarta acquisition https://www.gilead.com/news-and-press/press-room/press-releases/2017/8/gilead-sciences-to-acquire-kite-pharma-for-119-billion# https://www.gilead.com/news-and-press/press-room/press-relea...